Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Immuron Limited
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
August 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
August 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
August 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron announces record Travelan® sales globally, Australia and USA
July 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron requests pre-IND meeting for IMM-529 with FDA filing
July 02, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
June 05, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO Steven Lydeamore to present at Peak Sky High
May 31, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Board Changes
May 31, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Limited to Present at the Emerging Growth Conference
May 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Director Resignation
May 03, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron to host Live Virtual Event
April 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® sales continued strong growth
April 10, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
March 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Presentation Australian Biologics Festival 2024
February 21, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record Travelan® sales
February 13, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
February 08, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record half yearly Travelan® sales
January 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Clinical Trials Update
December 22, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
December 04, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
November 28, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO Steven Lydeamore Investor Webinar Presentation
November 13, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO Steven Lydeamore presented at AusBioInvest
October 30, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Travelan® Clinical Study Cohort 2 commences
October 18, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record quarterly Travelan® sales
October 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record monthly Travelan® sales
September 13, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
September 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron to present at the Military Health System Research Symposium
August 14, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
July 25, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at Bioshares
July 24, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Business Update - Ateria Health launches Juvia™ in Australia
July 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.